The use of polymer-based nanoparticles and nanostructured materials in treatment and diagnosis of cardiovascular diseases: Recent advances and emerging designs

Progress in Polymer Science

Volumn 57, Issue , 2016, Pages 153-178

  Wang, Yen Jen ^a   Larsson, Mikael ^b   Huang, Wei Ting ^a   Chiou, Shih Hwa ^c   Nicholls, Stephen J ^d   Chao, Jui I ^a   Liu, Dean Mo ^a  

^a NATIONAL CHIAO TUNG UNIVERSITY   (Taiwan)

^b UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

^c NATIONAL YANG MING UNIVERSITY   (Taiwan)

^d UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

Cardiovascular diseases; Drug delivery; Nanoparticles; Nanostructured; Polymers; Theranostic

Indexed keywords

CARDIOLOGY; DIAGNOSIS; DISEASE CONTROL; DRUG DELIVERY; NANOPARTICLES; NANOSTRUCTURED MATERIALS; POLYMERS; SCAFFOLDS (BIOLOGY);

CARDIO-VASCULAR DISEASE; CURRENT TREATMENTS; HEALTH-CARE SYSTEM; MATERIALS DEVELOPMENT; NANO-STRUCTURED; STATE OF THE ART; THERANOSTIC; THERANOSTIC NANOCARRIERS;

DISEASES;

EID: 84959914954     PISSN: 00796700     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.progpolymsci.2016.01.002     Document Type: Review

References (241)

1. M. Heron Deaths: leading causes for 2009 Natl Vital Stat Rep 61 6 2012 1 96
2. M. Nichols, N. Townsend, P. Scarborough, M. Rayner, J. Leal, R. Luengo-Fernandez, and A. Gray European Cardiovascular Disease Statistics 2012 Edition 2012 European Heart Network Brussels 125 pp.
3. R. Gupta, S. Guptha, K.K. Sharma, A. Gupta, and P. Deedwania Regional variations in cardiovascular risk factors in India: India heart watch World J Cardiol 4 2012 112 120
4. World Health Organization Factsheet on Cardiovascular Disease; 2015. www.who.int/mediacentre/factsheets/fs317/en/index.html [accessed January 2016].
5. D. Lloyd-Jones, R.J. Adams, T.M. Brown, M. Carnethon, S. Dai, G. De Simone, T.B. Ferguson, E. Ford, K. Furie, C. Gillespie, A. Go, K. Greenlund, N. Haase, S. Hailpern, P.M. Ho, V. Howard, B. Kissela, S. Kittner, D. Lackland, L. Lisabeth, A. Marelli, M.M. McDermott, J. Meigs, D. Mozaffarian, M. Mussolino, G. Nichol, V.L. Roger, W. Rosamond, R. Sacco, P. Sorlie, T. Thom, S. Wasserthiel-Smoller, N.D. Wong, and J. Wylie-Rosett Heart disease and stroke statistics-2010 Update: a report from the American Heart Association Circulation 121 2010 e46 e215
6. B. Godin, J.H. Sakamoto, R.E. Serda, A. Grattoni, A. Bouamrani, and M. Ferrari Emerging applications of nanomedicine for the diagnosis and treatment of cardiovascular diseases Trends Pharmacol Sci 31 2010 199 205
7. Z.M. Binsalamah, A. Paul, S. Prakash, and D. Shum-Tim Nanomedicine in cardiovascular therapy: recent advancements Expert Rev Cardiovasc Ther 10 2012 805 815
8. D. Gomez, and G.K. Owens Smooth muscle cell phenotypic switching in atherosclerosis Cardiovasc Res 95 2012 156 164
9. L.S. Shankman, D. Gomez, O.A. Cherepanova, M. Salmon, G.F. Alencar, R.M. Haskins, P. Swiatlowska, A.A.C. Newman, E.S. Greene, A.C. Straub, B. Isakson, G.J. Randolph, and G.K. Owens KLF4-dependent phenotypic modulation of smooth muscle cells has a key role in atherosclerotic plaque pathogenesis Nat Med 21 2015 628 637
10. L.L. Hilenski, and K.K. Griendling Vascular smooth muscle M.A. Creager, J.A. Beckman, J. Loscalzo, Vascular Medicine: A Companion to Braunwald's Heart Disease 2nd ed. 2013 WB Saunders Philadelphia 25 42
11. G.K. Owens, M.S. Kumar, and B.R. Wamhoff Molecular regulation of vascular smooth muscle cell differentiation in development and disease Physiol Rev 84 2004 767 801
12. M.G. Frid, A.A. Aldashev, E.C. Dempsey, and K.R. Stenmark Smooth muscle cells isolated from discrete compartments of the mature vascular media exhibit unique phenotypes and distinct growth capabilities Circ Res 81 1997 940 952
13. R.D. Kenagy, N. Fukai, S.K. Min, F. Jalikis, T.R. Kohler, and A.W. Clowes Proliferative capacity of vein graft smooth muscle cells and fibroblasts in vitro correlates with graft stenosis J Vasc Surg 49 2009 1282 1288
14. A.C. Newby An overview of the vascular response to injury: a tribute to the late Russell Ross Toxicol Lett 112-113 2000 519 529
15. C. Bauters, T. Meurice, M. Hamon, E. McFadden, J.M. Lablanche, and M.E. Bertrand Mechanisms and prevention of restenosis: from experimental models to clinical practice Cardiovasc Res 31 1996 835 846
16. M. Humbert, N.W. Morrell, S.L. Archer, K.R. Stenmark, M.R. MacLean, I.M. Lang, B.W. Christman, E.K. Weir, O. Eickelberg, N.F. Voelkel, and M. Rabinovitch Cellular and molecular pathobiology of pulmonary arterial hypertension J Am Coll Cardiol 43 2004 13S 24S
17. M. Parizek, K. Novotna, and L. Bacakova The role of smooth muscle cells in vessel wall pathophysiology and reconstruction using bioactive synthetic polymers Physiol Res 60 2011 419 437
18. N.C. Kaneider, C.M. Reinisch, S. Dunzendorfer, C. Meierhofer, A. Djanani, and C.J. Wiedermann Induction of apoptosis and inhibition of migration of inflammatory and vascular wall cells by cerivastatin Atherosclerosis 158 2001 23 33
19. T.L. Kaiura, H. Itoh, S.M. Kubaska III, T.A. McCaffrey, B. Liu, and K.C. Kent The effect of growth factors, cytokines, and extracellular matrix proteins on fibronectin production in human vascular smooth muscle cells J Vasc Surg 31 2000 577 584
20. C.A. Kavanagh, Y.A. Rochev, W.M. Gallagher, K.A. Dawson, and A.K. Keenan Local drug delivery in restenosis injury: thermoresponsive co-polymers as potential drug delivery systems Pharmacol Ther 102 2004 1 15
21. A.M. Lincoff, E.J. Topol, and S.G. Ellis Local drug delivery for the prevention of restenosis. Fact, fancy, and future Circulation 90 1994 2070 2084
22. Z.M. Gertz, and R.L. Wilensky Local drug delivery for treatment of coronary and peripheral artery disease Cardiovasc Ther 29 2011 e54 e66
23. T.K. Nasser, R.L. Wilensky, K. Mehdi, and K.L. March Microparticle deposition in periarterial microvasculature and intramural dissections after porous balloon delivery into atherosclerotic vessels: quantitation and localization by confocal scanning laser microscopy Am Heart J 131 1996 892 898
24. D.B. Fram, J.F. Mitchel, M.A. Azrin, M.S. Chow, D.D. Waters, and R.G. McKay Local delivery of heparin to balloon angioplasty sites with a new angiotherapy catheter: pharmacokinetics and effect on platelet deposition in the porcine model Cathet Cardiovasc Diagn 41 1997 275 286
25. M.A. Azrin, J.F. Mitchel, D.B. Fram, C.A. Pedersen, R.W. Cartun, J.J. Barry, L.M. Bow, D.D. Waters, and R.G. McKay Decreased platelet deposition and smooth muscle cell proliferation after intramural heparin delivery with hydrogel-coated balloons Circulation 90 1994 433 441
26. I. Gradus-Pizlo, R.L. Wilensky, K.L. March, N. Fineberg, M. Michaels, G.E. Sandusky, and D.R. Hathaway Local delivery of biodegradable microparticles containing colchicine or a colchicine analogue: effects on restenosis and implications for catheter-based drug delivery J Am Coll Cardiol 26 1995 1549 1557
27. S. Sharma, C. Christopoulos, N. Kukreja, and D.A. Gorog Local drug delivery for percutaneous coronary intervention Pharmacol Ther 129 2011 260 266
28. C. Psarros, R. Lee, M. Margaritis, and C. Antoniades Nanomedicine for the prevention, treatment and imaging of atherosclerosis Maturitas 73 2012 52 60
29. W.J. Mulder, and Z.A. Fayad Nanomedicine captures cardiovascular disease Arterioscler Thromb Vasc Biol 28 2008 801 802
30. H. Boulaiz, P.J. Alvarez, A. Ramirez, J.A. Marchal, J. Prados, F. Rodriguez-Serrano, M. Peran, C. Melguizo, and A. Aranega Nanomedicine: application areas and development prospects Int J Mol Sci 12 2011 3303 3321
31. D.R. Lewis, K. Kamisoglu, A.W. York, and P.V. Moghe Polymer-based therapeutics: nanoassemblies and nanoparticles for management of atherosclerosis Wiley Interdiscip Rev Nanomed Nanobiotechnol 3 2011 400 420
32. J. Shi, A.R. Votruba, O.C. Farokhzad, and R. Langer Nanotechnology in drug delivery and tissue engineering: from discovery to applications Nano Lett 10 2010 3223 3230
33. N. Ahmed, H. Fessi, and A. Elaissari Theranostic applications of nanoparticles in cancer Drug Discov Today 17 2012 928 934
34. D. Wang, B. Lin, and H. Ai Theranostic nanoparticles for cancer and cardiovascular applications Pharm Res 31 2014 1390 1406
35. A. Kowalczuk, R. Trzcinska, B. Trzebicka, A.H.E. Müller, A. Dworak, and C.B. Tsvetanov Loading of polymer nanocarriers: factors, mechanisms and applications Prog Polym Sci 39 2014 43 86
36. J.F. Mitchel, D.B. Fram, D.F. Palme II., R. Foster, J.A. Hirst, M.A. Azrin, L.M. Bow, A.M. Eldin, D.D. Waters, and R.G. McKay Enhanced intracoronary thrombolysis with urokinase using a novel, local drug delivery system. In vitro, in vivo, and clinical studies Circulation 91 1995 785 793
37. M.L. Adams, A. Lavasanifar, and G.S. Kwon Amphiphilic block copolymers for drug delivery J Pharm Sci 92 2003 1343 1355
38. M. Larsson, W.C. Huang, M.H. Hsiao, Y.J. Wang, M. Nydén, S.H. Chiou, and D.M. Liu Biomedical applications and colloidal properties of amphiphilically modified chitosan hybrids Prog Polym Sci 38 2013 1307 1328
39. Z.L. Tyrrell, Y. Shen, and M. Radosz Fabrication of micellar nanoparticles for drug delivery through the self-assembly of block copolymers Prog Polym Sci 35 2010 1128 1143
40. L. Tian, L. Yam, N. Zhou, H. Tat, and K.E. Uhrich Amphiphilic scorpion-like macromolecules: design, synthesis, and characterization Macromolecules 37 2003 538 543
41. S. Hehir, N.M. Plour, L. Gu, D.E. Poree, W.J. Welsh, P.V. Moghe, and K.E. Uhrich Carbohydrate composition of amphiphilic macromolecules influences physicochemical properties and binding to atherogenic scavenger receptor A Acta Biomater 8 2012 3956 3962
42. K.H. Liu, S.Y. Chen, D.M. Liu, and T.Y. Liu Self-assembled hollow nanocapsule from amphiphatic carboxymethyl-hexanoyl chitosan as drug carrier Macromolecules 41 2008 6511 6516
43. K.H. Liu, B.R. Chen, S.Y. Chen, and D.M. Liu Self-assembly behavior and doxorubicin-loading capacity of acylated carboxymethyl chitosans J Phys Chem B 113 2009 11800 11807
44. P.J. Photos, L. Bacakova, B. Discher, F.S. Bates, and D.E. Discher Polymer vesicles in vivo: correlations with PEG molecular weight J Controlled Release 90 2003 323 334
45. E. Soussan, S. Cassel, M. Blanzat, and I. Rico-Lattes Drug delivery by soft matter: matrix and vesicular carriers Angew Chem Int Ed 48 2009 274 288
46. J. Shi, Z. Xiao, N. Kamaly, and O.C. Farokhzad Self-assembled targeted nanoparticles: evolution of technologies and bench to bedside translation Acc Chem Res 44 2011 1123 1134
47. R. Wang, R. Xiao, Z. Zeng, L. Xu, and J. Wang Application of poly(ethylene glycol)-distearoylphosphatidylethanolamine (PEG-DSPE) block copolymers and their derivatives as nanomaterials in drug delivery Int J Nanomed 7 2012 4185 4198
48. M.L. Hans, and A.M. Lowman Biodegradable nanoparticles for drug delivery and targeting Curr Opin Solid State Mater Sci 6 2002 319 327
49. M.C. Chen, H.W. Tsai, C.T. Liu, S.F. Peng, W.Y. Lai, S.J. Chen, Y. Chang, and H.W. Sung A nanoscale drug-entrapment strategy for hydrogel-based systems for the delivery of poorly soluble drugs Biomaterials 30 2009 2102 2111
50. K. Park, H.Y. Hong, H.J. Moon, B.H. Lee, I.S. Kim, I.C. Kwon, and K. Rhee A new atherosclerotic lesion probe based on hydrophobically modified chitosan nanoparticles functionalized by the atherosclerotic plaque targeted peptides J Controlled Release 128 2008 217 223
51. T. Uwatoku, H. Shimokawa, K. Abe, Y. Matsumoto, T. Hattori, K. Oi, T. Matsuda, K. Kataoka, and A. Takeshita Application of nanoparticle technology for the prevention of restenosis after balloon injury in rats Circ Res 92 2003 e62 e69
52. M. Chorny, I. Fishbein, B.B. Yellen, I.S. Alferiev, M. Bakay, S. Ganta, R. Adamo, M. Amiji, G. Friedman, and R.J. Levy Targeting stents with local delivery of paclitaxel-loaded magnetic nanoparticles using uniform fields Proc Nat Acad Sci USA 107 2010 8346 8351
53. J.M. Chan, L. Zhang, R. Tong, D. Ghosh, W. Gao, G. Liao, K.P. Yuet, D. Gray, J.W. Rhee, J. Cheng, G. Golomb, P. Libby, R. Langer, and O.C. Farokhzad Spatiotemporal controlled delivery of nanoparticles to injured vasculature Proc Nat Acad Sci USA 107 2010 2213 2218
54. C. Song, V. Labhasetwar, X. Cui, T. Underwood, and R.J. Levy Arterial uptake of biodegradable nanoparticles for intravascular local drug delivery: results with an acute dog model J Controlled Release 54 1998 201 211
55. J.E. Blackwell, N.M. Dagia, J.B. Dickerson, E.L. Berg, and D.J. Goetz Ligand coated nanosphere adhesion to E- and P-selectin under static and flow conditions Ann Biomed Eng 29 2001 523 533
56. J. Han, B.J. Zern, V.V. Shuvaev, P.F. Davies, S. Muro, and V. Muzykantov Acute and chronic shear stress differently regulate endothelial internalization of nanocarriers targeted to platelet-endothelial cell adhesion molecule-1 ACS Nano 6 2012 8824 8836
57. N. Korin, M. Kanapathipillai, B.D. Matthews, M. Crescente, A. Brill, T. Mammoto, K. Ghosh, S. Jurek, S.A. Bencherif, D. Bhatta, A.U. Coskun, C.L. Feldman, D.D. Wagner, and D.E. Ingber Shear-activated nanotherapeutics for drug targeting to obstructed blood vessels Science 337 2012 738 742
58. J.C. Stendahl, and A.J. Sinusas Nanoparticles for cardiovascular imaging and therapeutic delivery, Part 1: Compositions and features J Nucl Med 56 2015 1469 1475
59. M.J. Ernsting, M. Murakami, A. Roy, and S.D. Li Factors controlling the pharmacokinetics, biodistribution and intratumoral penetration of nanoparticles J Controlled Release 172 2013 782 794
60. S.D. Li, and L. Huang Pharmacokinetics and biodistribution of nanoparticles Mol Pharm 5 2008 496 504
61. S.M. Moghimi, A.C. Hunter, and T.L. Andresen Factors controlling nanoparticle pharmacokinetics: an integrated analysis and perspective Annu Rev Pharmacol Toxicol 52 2012 481 503
62. C. Zhu Endothelial progenitor (EPC)-seeded intravascular stents R.K. Li, R.D. Weisel, Cardiac Regeneration and Repair: Biomaterials and Tissue Engineering 2014 Woodhead Publishing Ltd. Cambridge UK 110 124
63. J. Waugh, and A.J. Wagstaff The Paclitaxel (TAXUS)-eluting stent: a review of its use in the management of de novo coronary artery lesions Am J Cardiovasc Drugs 4 2004 257 268
64. K.G. Reuter, J.L. Perry, D. Kim, J.C. Luft, R. Liu, and J.M. DeSimone Targeted PRINT hydrogels: the role of nanoparticle size and ligand density on cell association, biodistribution, and tumor accumulation Nano Lett 15 2015 6371 6378
65. R.A. Petros, and J.M. DeSimone Strategies in the design of nanoparticles for therapeutic applications Nat Rev Drug Discov 9 2010 615 627
66. D. Pozzi, V. Colapicchioni, G. Caracciolo, S. Piovesana, A.L. Capriotti, S. Palchetti, S. De Grossi, A. Riccioli, H. Amenitsch, and A. Lagana Effect of polyethyleneglycol (PEG) chain length on the bio-nano-interactions between PEGylated lipid nanoparticles and biological fluids: from nanostructure to uptake in cancer cells Nanoscale 6 2014 2782 2792
67. K. Cho, X. Wang, S. Nie, Z. Chen, and D.M. Shin Therapeutic nanoparticles for drug delivery in cancer Clin Cancer Res 14 2008 1310 1316
68. H.S. Choi, W. Liu, P. Misra, E. Tanaka, J.P. Zimmer, B. Itty Ipe, M.G. Bawendi, and J.V. Frangioni Renal clearance of quantum dots Nat Biotechnol 25 2007 1165 1170
69. S.M. Moghimi, A.C. Hunter, and J.C. Murray Long-circulating and target-specific nanoparticles: theory to practice Pharmacol Rev 53 2001 283 318
70. K.A. Athanasiou, G.G. Niederauer, and C.M. Agrawal Sterilization, toxicity, biocompatibility and clinical applications of polylactic acid/polyglycolic acid copolymers Biomaterials 17 1996 93 102
71. C.X. Song, V. Labhasetwar, H. Murphy, X. Qu, W.R. Humphrey, R.J. Shebuski, and R.J. Levy Formulation and characterization of biodegradable nanoparticles for intravascular local drug delivery J Controlled Release 43 1997 197 212
72. W. Zou, G. Cao, Y. Xi, and N. Zhang New approach for local delivery of rapamycin by bioadhesive PLGA-carbopol nanoparticles Drug Deliv 16 2009 15 23
73. E. Cohen-Sela, S. Teitlboim, M. Chorny, N. Koroukhov, H.D. Danenberg, J. Gao, and G. Golomb Single and double emulsion manufacturing techniques of an amphiphilic drug in PLGA nanoparticles: formulations of mithramycin and bioactivity J Pharm Sci 98 2009 1452 1462
74. H. Cohen-Sacks, Y. Najajreh, V. Tchaikovski, G. Gao, V. Elazer, R. Dahan, I. Gati, M. Kanaan, J. Waltenberger, and G. Golomb Novel PDGFbetaR antisense encapsulated in polymeric nanospheres for the treatment of restenosis Gene Ther 9 2002 1607 1616
75. J. Varshosaz, and M. Soheili Production and in vitro characterization of lisinopril-loaded nanoparticles for the treatment of restenosis in stented coronary arteries J Microencapsul 25 2008 478 486
76. V. Labhasetwar, C. Song, W. Humphrey, R. Shebuski, and R.J. Levy Arterial uptake of biodegradable nanoparticles: effect of surface modifications J Pharm Sci 87 1998 1229 1234
77. E. Cohen-Sela, O. Rosenzweig, J. Gao, H. Epstein, I. Gati, R. Reich, H.D. Danenberg, and G. Golomb Alendronate-loaded nanoparticles deplete monocytes and attenuate restenosis J Controlled Release 113 2006 23 30
78. K. Liu, G. Cao, X. Zhang, R. Liu, W. Zou, and S. Wu Pretreatment with intraluminal rapamycin nanoparticle perfusion inhibits neointimal hyperplasia in a rabbit vein graft model Int J Nanomed 5 2010 853 860
79. J. Yang, Y. Zeng, Y. Li, C. Song, W. Zhu, H. Guan, and X. Li Intravascular site-specific delivery of a therapeutic antisense for the inhibition of restenosis Eur J Pharm Sci 35 2008 427 434
80. E. Cohen-Sela, M. Chorny, N. Koroukhov, H.D. Danenberg, and G. Golomb A new double emulsion solvent diffusion technique for encapsulating hydrophilic molecules in PLGA nanoparticles J Controlled Release 133 2009 90 95
81. J. Davda, and V. Labhasetwar Characterization of nanoparticle uptake by endothelial cells Int J Pharm 233 2002 51 59
82. L.A. Guzman, V. Labhasetwar, C. Song, Y. Jang, A.M. Lincoff, R. Levy, and E.J. Topol Local intraluminal infusion of biodegradable polymeric nanoparticles. A novel approach for prolonged drug delivery after balloon angioplasty Circulation 94 1996 1441 1448
83. U. Westedt, L. Barbu-Tudoran, A.K. Schaper, M. Kalinowski, H. Alfke, and T. Kissel Deposition of nanoparticles in the arterial vessel by porous balloon catheters: localization by confocal laser scanning microscopy and transmission electron microscopy AAPS PharmSci 4 2002 206 211
84. J.J. Rome, V. Shayani, M.Y. Flugelman, K.D. Newman, A. Farb, R. Virmani, and D.A. Dichek Anatomic barriers influence the distribution of in vivo gene transfer into the arterial wall. Modeling with microscopic tracer particles and verification with a recombinant adenoviral vector Arterioscler Thromb Vasc Biol 14 1994 148 161
85. D.E. Discher, V. Ortiz, G. Srinivas, M.L. Klein, Y. Kim, D. Christian, S. Cai, P. Photos, and F. Ahmed Emerging applications of polymersomes in delivery: from molecular dynamics to shrinkage of tumors Prog Polym Sci 32 2007 838 857
86. H. Meng, S. Yang, Z. Li, T. Xia, J. Chen, Z. Ji, H. Zhang, X. Wang, S. Lin, C. Huang, Z.H. Zhou, J.I. Zink, and A.E. Nel Aspect ratio determines the quantity of mesoporous silica nanoparticle uptake by a small GTPase-dependent macropinocytosis mechanism ACS Nano 5 2011 4434 4447
87. N. Doshi, and S. Mitragotri Needle-shaped polymeric particles induce transient disruption of cell membranes J R Soc Interface 7 suppl 4 2010 S403 S410
88. J. Kreuter Mechanism of polymeric nanoparticle-based drug transport across the blood-brain barrier (BBB) J Microencapsul 30 2013 49 54
89. A. Verma, and F. Stellacci Effect of surface properties on nanoparticle-cell interactions Small 6 2010 12 21
90. A. Albanese, P.S. Tang, and W.C.W. Chan The effect of nanoparticle size, shape, and surface chemistry on biological systems Annu Rev Biomed Eng 14 2012 1 16
91. V. Javvaji, M.B. Dowling, H. Oh, I.M. White, and S.R. Raghavan Reversible gelation of cells using self-assembling hydrophobically-modified biopolymers: towards self-assembly of tissue Biomater Sci 2 2014 1016 1023
92. M.B. Dowling, R. Kumar, M.A. Keibler, J.R. Hess, G.V. Bochicchio, and S.R. Raghavan A self-assembling hydrophobically modified chitosan capable of reversible hemostatic action Biomaterials 32 2011 3351 3357
93. A.C. Zago, J.C. Raudales, G. Attizzani, B.S. Matte, G.I. Yamamoto, J.A. Balvedi, L. Nascimento, B.G. Kosachenco, P.R. Centeno, and A.J. Zago Local delivery of sirolimus nanoparticles for the treatment of in-stent restenosis Catheter Cardiovasc Interv 81 2013 E124 E129
94. J. Tan, S. Shah, A. Thomas, H.D. Ou-Yang, and Y. Liu The influence of size, shape and vessel geometry on nanoparticle distribution Microfluid Nanofluid 14 2013 77 87
95. S. Shah, Y. Liu, W. Hu, and J. Gao Modeling particle shape-dependent dynamics in nanomedicine J Nanosci Nanotechnol 11 2011 919 928
96. V.V. Shuvaev, M.A. Ilies, E. Simone, S. Zaitsev, Y. Kim, S. Cai, A. Mahmud, T. Dziubla, S. Muro, D.E. Discher, and V.R. Muzykantov Endothelial targeting of antibody-decorated polymeric filomicelles ACS Nano 5 2011 6991 6999
97. K. Park, J.H. Kim, Y.S. Nam, S. Lee, H.Y. Nam, K. Kim, J.H. Park, I.S. Kim, K. Choi, S.Y. Kim, and I.C. Kwon Effect of polymer molecular weight on the tumor targeting characteristics of self-assembled glycol chitosan nanoparticles J Controlled Release 122 2007 305 314
98. U. Westedt, M. Kalinowski, M. Wittmar, T. Merdan, F. Unger, J. Fuchs, S. Schäller, U. Bakowsky, and T. Kissel Poly(vinyl alcohol)-graft-poly(lactide-co-glycolide) nanoparticles for local delivery of paclitaxel for restenosis treatment J Controlled Release 119 2007 41 51
99. A. Breitenbach, K.F. Pistel, and T. Kissel Biodegradable comb polyesters, Part II. Erosion and release properties of poly(vinyl alcohol)-g-poly(lactic-co-glycolic acid) Polymer 41 2000 4781 4792
100. G. Lippi, C. Mattiuzzi, and E.J. Favaloro Novel and emerging therapies: thrombus-targeted fibrinolysis Semin Thromb Hemost 39 2013 48 58
101. G. Patti, V. Pasceri, P. Carminati, A. D'Ambrosio, A. Carcagnì, and G. Di Sciascio Effect of dexamethasone-eluting stents on systemic inflammatory response in patients with unstable angina pectoris or recent myocardial infarction undergoing percutaneous coronary intervention Am J Cardiol 95 2005 502 505
102. A.C. Zago, B.S. Matte, L. Reginato, G. Iturry-Yamamoto, A. Krepsky, L.C. Bergoli, J. Balvedi, J.C. Raudales, E.K. Saadi, and A.J. Zago First-in-man study of simvastatin-eluting stent in de novo coronary lesions: the SIMVASTENT study Circ J 76 2012 1109 1114
103. D.E. Kandzari, M.B. Leon, I. Meredith, J. Fajadet, W. Wijns, and L. Mauri Final 5-year outcomes from the endeavor zotarolimus-eluting stent clinical trial program: comparison of safety and efficacy with first-generation drug-eluting and bare-metal stents JACC Cardiovasc Interv 6 2013 504 512
104. Y. Zhang, J. Shen, Z. Li, A. Zhu, Y. Yuan, R. Yue, J. Yuan, Y. Yin, Q. She, and Y. Chen Two-year clinical outcomes of different drug-eluting stents with different polymer coating strategies in coronary artery heart disease: a multi-centre, randomised, controlled clinical trial Int J Cardiol 168 2013 2646 2652
105. T. Nakanishi, S. Fukushima, K. Okamoto, M. Suzuki, Y. Matsumura, M. Yokoyama, T. Okano, Y. Sakurai, and K. Kataoka Development of the polymer micelle carrier system for doxorubicin J Controlled Release 74 2001 295 302
106. J. Panyam, and V. Labhasetwar Sustained cytoplasmic delivery of drugs with intracellular receptors using biodegradable nanoparticles Mol Pharm 1 2004 77 84
107. I. Fishbein, M. Chorny, L. Rabinovich, S. Banai, I. Gati, and G. Golomb Nanoparticulate delivery system of a tyrphostin for the treatment of restenosis J Controlled Release 65 2000 221 229
108. S. Banai, Y. Wolf, G. Golomb, A. Pearle, J. Waltenberger, I. Fishbein, A. Schneider, A. Gazit, L. Perez, R. Huber, G. Lazarovichi, L. Rabinovich, A. Levitzki, and S.D. Gertz PDGF-receptor tyrosine kinase blocker AG1295 selectively attenuates smooth muscle cell growth in vitro and reduces neointimal formation after balloon angioplasty in swine Circulation 97 1998 1960 1969
109. S. Banai, M. Chorny, S.D. Gertz, I. Fishbein, J. Gao, L. Perez, G. Lazarovichi, A. Gazit, A. Levitzki, and G. Golomb Locally delivered nanoencapsulated tyrphostin (AGL-2043) reduces neointima formation in balloon-injured rat carotid and stented porcine coronary arteries Biomaterials 26 2005 451 461
110. A. San Martín, and K.K. Griendling Redox control of vascular smooth muscle migration Antioxid Redox Signaling 12 2010 625 640
111. S.M. Weakley, X. Wang, H. Mu, J. Lu, P.H. Lin, Q. Yao, and C. Chen Ginkgolide A-gold nanoparticles inhibit vascular smooth muscle proliferation and migration in vitro and reduce neointimal hyperplasia in a mouse model J Surg Res 171 2011 31 39
112. U.G. Spizzirri, F. Iemma, F. Puoci, G. Cirillo, M. Curcio, O.I. Parisi, and N. Picci Synthesis of antioxidant polymers by grafting of gallic acid and catechin on gelatin Biomacromolecules 10 2009 1923 1930
113. B. KoŠíková, J. Lábaj, A. Gregorová, and D. Slameňová Lignin antioxidants for preventing oxidation damage of DNA and for stabilizing polymeric composites Holzforschung 60 2006 166 170
114. H. Uyama, and Y.J. Kim Synthesis and applications of polymeric flavonoids G. Cirilo, F. Iemma, Antioxidant Polymers 2012 John Wiley & Sons Inc. New York 55 86
115. H. Uyama Artificial polymeric flavonoids: synthesis and applications Macromol Biosci 7 2007 410 422
116. S. Trombino, R. Cassano, E. Bloise, R. Muzzalupo, S. Leta, F. Puoci, and N. Picci Design and synthesis of cellulose derivatives with antioxidant activity Macromol Biosci 8 2008 86 95
117. F. Sousa, G.M. Guebitz, and V. Kokol Antimicrobial and antioxidant properties of chitosan enzymatically functionalized with flavonoids Process Biochem 44 2009 749 756
118. J. Vinsova, and E. Vavrikova Chitosan derivatives with antimicrobial, antitumour and antioxidant activities - a review Curr Pharm Des 17 2011 3596 3607
119. F. Sharif, K. Daly, J. Crowley, and T. O'Brien Current status of catheter- and stent-based gene therapy Cardiovasc Res 64 2004 208 216
120. A. Paul, W. Shao, D. Shum-Tim, and S. Prakash The attenuation of restenosis following arterial gene transfer using carbon nanotube coated stent incorporating TAT/DNA(Ang1 + Vegf) nanoparticles Biomaterials 33 2012 7655 7664
121. J. Yang, Y. Zeng, C. Zhang, Y.X. Chen, Z. Yang, Y. Li, X. Leng, D. Kong, X.Q. Wei, H.F. Sun, and C.X. Song The prevention of restenosis in vivo with a VEGF gene and paclitaxel co-eluting stent Biomaterials 34 2013 1635 1643
122. H.L. Che, I.H. Bae, K.S. Lim, I.T. Song, H. Lee, M. Muthiah, R. Namgung, W.J. Kim, D.G. Kim, Y. Ahn, M.H. Jeong, and I.K. Park Suppression of post-angioplasty restenosis with an Akt1 siRNA-embedded coronary stent in a rabbit model Biomaterials 33 2012 8548 8556
123. M. Chorny, I. Fishbein, I. Alferiev, and R.J. Levy Magnetically responsive biodegradable nanoparticles enhance adenoviral gene transfer in cultured smooth muscle and endothelial cells Mol Pharm 6 2009 1380 1387
124. M.C. Lenter, P. Garidel, J. Pelisek, E. Wagner, and M. Ogris Stabilized nonviral formulations for the delivery of MCP-1 gene into cells of the vasculoendothelial system Pharm Res 21 2004 683 691
125. S.D. Patil, D.G. Rhodes, and D.J. Burgess DNA-based therapeutics and DNA delivery systems: a comprehensive review AAPS J 7 2005 E61 E77
126. D. Kim, D. Lee, Y.L. Jang, S.Y. Chae, D. Choi, J.H. Jeong, and S.H. Kim Facial amphipathic deoxycholic acid-modified polyethyleneimine for efficient MMP-2 siRNA delivery in vascular smooth muscle cells Eur J Pharm Biopharm 81 2012 14 23
127. X. Jin, L. Mei, C. Song, L. Liu, X. Leng, H. Sun, D. Kong, and R.J. Levy Immobilization of plasmid DNA on an anti-DNA antibody modified coronary stent for intravascular site-specific gene therapy J Gene Med 10 2008 421 429
128. T. Ichiki, and J.C. Burnett Jr. Protein therapeutics for cardiovascular disease: it is all about delivery J Am Coll Cardiol 60 2012 2558 2560
129. K. Zhu, H. Lai, C. Guo, D. Xu, and C. Wang Novel vascular endothelial growth factor gene delivery system-manipulated mesenchymal stem cells repair infarcted myocardium Exp Biol Med 237 2012 678 687
130. H. Kawata, Y. Uesugi, T. Soeda, Y. Takemoto, J.H. Sung, K. Umaki, K. Kato, K. Ogiwara, K. Nogami, K. Ishigami, M. Horii, S. Uemura, M. Shima, Y. Tabata, and Y. Saito A new drug delivery system for intravenous coronary thrombolysis with thrombus targeting and stealth activity recoverable by ultrasound J Am Coll Cardiol 60 2012 2550 2557
131. Y. Uesugi, H. Kawata, Y. Saito, and Y. Tabata Ultrasound-responsive thrombus treatment with zinc-stabilized gelatin nano-complexes of tissue-type plasminogen activator J Drug Target 20 2012 224 234
132. D.S. Pisal, M.P. Kosloski, and S.V. Balu-Iyer Delivery of therapeutic proteins J Pharm Sci 99 2010 2557 2575
133. K.Y. Lee, and S.H. Yuk Polymeric protein delivery systems Prog Polym Sci 32 2007 669 697
134. H. Cohen, R.J. Levy, J. Gao, I. Fishbein, V. Kousaev, S. Sosnowski, S. Slomkowski, and G. Golomb Sustained delivery and expression of DNA encapsulated in polymeric nanoparticles Gene Ther 7 2000 1896 1905
135. A. Baoum, N. Dhillon, S. Buch, and C. Berkland Cationic surface modification of PLG nanoparticles offers sustained gene delivery to pulmonary epithelial cells J Pharm Sci 99 2010 2413 2422
136. M. Figueiredo, and R. Esenaliev PLGA nanoparticles for ultrasound-mediated gene delivery to solid tumors J Drug Deliv 2012 2012 767839/1-20
137. W.T. Godbey, K.K. Wu, and A.G. Mikos Poly(ethylenimine)-mediated gene delivery affects endothelial cell function and viability Biomaterials 22 2001 471 480
138. S. Raghunathan, and B.M. Patel Therapeutic implications of small interfering RNA in cardiovascular diseases Fundam Clin Pharmacol 27 2013 1 20
139. R.J. Levy, C. Song, S. Tallapragada, S. DeFelice, J.T. Hinson, N. Vyavahare, J. Connolly, K. Ryan, and Q. Li Localized adenovirus gene delivery using antiviral IgG complexation Gene Ther 8 2001 659 667
140. W.J. van der Giessen, A.M. Lincoff, R.S. Schwartz, H.M. van Beusekom, P.W. Serruys, D.R. Holmes Jr., S.G. Ellis, and E.J. Topol Marked inflammatory sequelae to implantation of biodegradable and nonbiodegradable polymers in porcine coronary arteries Circulation 94 1996 1690 1697
141. D. Zhu, X. Jin, X. Leng, H. Wang, J. Bao, W. Liu, K. Yao, and C. Song Local gene delivery via endovascular stents coated with dodecylated chitosan-plasmid DNA nanoparticles Int J Nanomed 5 2010 1095 1102
142. D. Wang, Y. Zhuang, Y. Tian, G.N. Thomas, M. Ying, and B. Tomlinson Study of the effects of total flavonoids of Astragalus on atherosclerosis formation and potential mechanisms Oxid Med Cell Longev 2012 2012 282383/1-10
143. C.Y. Moon, C.R. Ku, Y.H. Cho, and E.J. Lee Protocatechuic aldehyde inhibits migration and proliferation of vascular smooth muscle cells and intravascular thrombosis Biochem Biophys Res Commun 423 2012 116 121
144. S. Wang, Y. Chen, D. He, L. He, Y. Yang, J. Chen, and X. Wang Inhibition of vascular smooth muscle cell proliferation by serum from rats treated orally with Gastrodia and Uncaria decoction, a traditional Chinese formulation J Ethnopharmacol 114 2007 458 462
145. G. Leonarduzzi, G. Testa, B. Sottero, P. Gamba, and G. Poli Design and development of nanovehicle-based delivery systems for preventive or therapeutic supplementation with flavonoids Curr Med Chem 17 2010 74 95
146. S. He, Z. Zhang, F. Xu, S. Zhang, and Z. Lei Micronization of magnolia bark extract with enhanced dissolution behavior by rapid expansion of supercritical solution Chem Pharm Bull 58 2010 154 159
147. Y.J. Wang, Y.C. Chien, C.H. Wu, and D.M. Liu Magnolol-loaded core-shell hydrogel nanoparticles: drug release, intracellular uptake, and controlled cytotoxicity for the inhibition of migration of vascular smooth muscle cells Mol Pharm 8 2011 2339 2349
148. Y.J. Wang, H.Y. Lin, C.H. Wu, and D.M. Liu Forming of demethoxycurcumin nanocrystallite-chitosan nanocarrier for controlled low dose cellular release for inhibition of the migration of vascular smooth muscle cells Mol Pharm 9 2012 2268 2279
149. H.P. Luehmann, E.D. Pressly, L. Detering, C. Wang, R. Pierce, P.K. Woodard, R.J. Gropler, C.J. Hawker, and Y. Liu PET/CT imaging of chemokine receptor CCR5 in vascular injury model using targeted nanoparticle J Nucl Med 55 2014 629 634
150. Y. Liu, E.D. Pressly, D.R. Abendschein, C.J. Hawker, G.E. Woodard, P.K. Woodard, and M.J. Welch Targeting angiogenesis using a C-type atrial natriuretic factor-conjugated nanoprobe and PET J Nucl Med 52 2011 1956 1963
151. 64Cu-labeled LyP-1-dendrimer for PET-CT imaging of atherosclerotic plaque Bioconjugate Chem 25 2014 231 239
152. D. Pan, S.D. Caruthers, A. Senpan, C. Yalaz, A.J. Stacy, G. Hu, J.N. Marsh, P.J. Gaffney, S.A. Wickline, and G.M. Lanza Synthesis of nanoq, a copper-based contrast agent for high-resolution magnetic resonance imaging characterization of human thrombus J Am Chem Soc 133 2011 9168 9171
153. W.J.M. Mulder, G.J. Strijkers, K.C. Briley-Saboe, J.C. Frias, J.G.S. Aguinaldo, E. Vucic, V. Amirbekian, C. Tang, P.T.K. Chin, K. Nicolay, and Z.A. Fayad Molecular imaging of macrophages in atherosclerotic plaques using bimodal PEG-micelles Magn Reson Med 58 2007 1164 1170
154. C.J. Anderson, J.W.M. Bulte, K. Chen, X. Chen, B.A. Khaw, M. Shokeen, K.L. Wooley, and H.F. VanBrocklin Design of targeted cardiovascular molecular imaging probes J Nucl Med 51 2010 3S 17S
155. A. Almutairi, R. Rossin, M. Shokeen, A. Hagooly, A. Ananth, B. Capoccia, S. Guillaudeu, D. Abendschein, C.J. Anderson, M.J. Welch, and J.M.J. Fréchet Biodegradable dendritic positron-emitting nanoprobes for the noninvasive imaging of angiogenesis Proc Nat Acad Sci USA 106 2009 685 690
156. J.M. Chan, J.W. Rhee, C.L. Drum, R.T. Bronson, G. Golomb, R. Langer, and O.C. Farokhzad In vivo prevention of arterial restenosis with paclitaxel-encapsulated targeted lipid-polymeric nanoparticles Proc Nat Acad Sci USA 108 2011 19347 19352
157. S. Marrache, and S. Dhar Biodegradable synthetic high-density lipoprotein nanoparticles for atherosclerosis Proc Nat Acad Sci USA 110 2013 9445 9450
158. M.Y. Chang, Y.J. Yang, C.H. Chang, A.C.L. Tang, W.Y. Liao, F.Y. Cheng, C.S. Yeh, J.J. Lai, P.S. Stayton, and P.C.H. Hsieh Functionalized nanoparticles provide early cardioprotection after acute myocardial infarction J Controlled Release 170 2013 287 294
159. Z.M. Binsalamah, A. Paul, A.A. Khan, S. Prakash, and D. Shum-Tim Intramyocardial sustained delivery of placental growth factor using nanoparticles as a vehicle for delivery in the rat infarct model Int J Nanomed 2011 6 2011 2667 2678
160. C.K. Kim, T. Kim, I.Y. Choi, M. Soh, D. Kim, Y.J. Kim, H. Jang, H.S. Yang, J.Y. Kim, H.K. Park, S.P. Park, S. Park, T. Yu, B.W. Yoon, S.H. Lee, and T. Hyeon Ceria nanoparticles that can protect against ischemic stroke Angew Chem Int Ed 51 2012 11039 11043
161. X. Yun, V.D. Maximov, J. Yu, H. Zhu, A.A. Vertegel, and M.S. Kindy Nanoparticles for targeted delivery of antioxidant enzymes to the brain after cerebral ischemia and reperfusion injury J Cereb Blood Flow Metab 33 2013 583 592
162. A. Mdzinarishvili, V. Sutariya, P. Talasila, W. Geldenhuys, and P. Sadana Engineering triiodothyronine (T3) nanoparticle for use in ischemic brain stroke Drug Deliv Transl Res 3 2013 309 317
163. X. Liu, C. An, P. Jin, X. Liu, and L. Wang Protective effects of cationic bovine serum albumin-conjugated PEGylated tanshinone IIA nanoparticles on cerebral ischemia Biomaterials 34 2013 817 830
164. L.X. Zhao, A.C. Liu, S.W. Yu, Z.X. Wang, X.Q. Lin, G.X. Zhai, and Q.Z. Zhang The permeability of puerarin loaded poly(butylcyanoacrylate) nanoparticles coated with polysorbate 80 on the blood-brain barrier and its protective effect against cerebral ischemia/reperfusion injury Biol Pharm Bull 36 2013 1263 1270
165. Y. Yang, and G.A. Rosenberg Blood-brain barrier breakdown in acute and chronic cerebrovascular disease Stroke 42 2011 3323 3328
166. J. Tang, Y. Sheng, H. Hu, and Y. Shen Macromolecular MRI contrast agents: structures, properties and applications Prog Polym Sci 38 2013 462 502
167. K.I. Fukukawa, R. Rossin, A. Hagooly, E.D. Pressly, J.N. Hunt, B.W. Messmore, K.L. Wooley, M.J. Welch, and C.J. Hawker Synthesis and characterization of core-shell star copolymers for in vivo PET imaging applications Biomacromolecules 9 2008 1329 1339
168. P. Woodard NCT02417688: PET imaging of natriuretic peptide receptor C (NPR-C) in carotid atherosclerosis ClinicalTrials.gov 2015 [accessed January 2016]
169. M.D. Majmudar, J. Yoo, E.J. Keliher, J.J. Truelove, Y. Iwamoto, B. Sena, P. Dutta, A. Borodovsky, K. Fitzgerald, M.F. Di Carli, P. Libby, D.G. Anderson, F.K. Swirski, R. Weissleder, and M. Nahrendorf Polymeric nanoparticle PET/MR imaging allows macrophage detection in atherosclerotic plaques Circ Res 112 2013 755 761
170. D. Patel, J.Y. Moon, Y. Chang, T.J. Kim, and G.H. Lee Poly(d,l-lactide-co-glycolide) coated superparamagnetic iron oxide nanoparticles: synthesis, characterization and in vivo study as MRI contrast agent Colloids Surf A 313-314 2008 91 94
171. J. Xie, G. Liu, H.S. Eden, H. Ai, and X. Chen Surface-engineered magnetic nanoparticle platforms for cancer imaging and therapy Acc Chem Res 44 2011 883 892
172. Z.R. Lu Theranostics: fusion of therapeutics and diagnostics Pharm Res 31 2014 1355 1357
173. M. Schiener, M. Hossann, J.R. Viola, A. Ortega-Gomez, C. Weber, K. Lauber, L.H. Lindner, and O. Soehnlein Nanomedicine-based strategies for treatment of atherosclerosis Trends Mol Med 20 2014 271 281
174. H. Hwang, J. Kwon, P.S. Oh, T.K. Lee, K.S. Na, C.M. Lee, H.S. Jeong, S.T. Lim, M.H. Sohn, and H.J. Jeong Peptide-loaded nanoparticles and radionuclide imaging for individualized treatment of myocardial ischemia Radiology 273 2014 160 167
175. N.A. Nikitina, E.M. Khalilov, T.I. Torkhovskaya, V.V. Tertov, and A.N. Orekhov Polyunsaturated phosphatidylcholine micelle-induced decrease of atherogenicity of the serumin vitro Bull Exp Biol Med 119 1995 480 483
176. Y.T. Yu, H. Zhu, and S. Wang Amphiphilic polyvinyl alcohol adsorbent for the removal of low-density lipoprotein Artif Cells Nanomed Biotechnol 43 2015 117 123
177. X. Hou, T. Zhang, and A. Cao Preparation of new amphiphilic macroporous nonwoven polymeric adsorbents aimed for selective removal of low-density lipoprotein from plasma J Biomed Mater Res Part B 103 2015 52 61
178. X. Hou, T. Zhang, and A. Cao A heparin modified polypropylene non-woven fabric membrane adsorbent for selective removal of low density lipoprotein from plasma Polym Adv Technol 24 2013 660 667
179. J. Li, Y. Hou, X. Chen, X. Ding, Y. Liu, X. Shen, and K. Cai Recyclable heparin and chitosan conjugated magnetic nanocomposites for selective removal of low-density lipoprotein from plasma J Mater Sci Mater Med 25 2014 1055 1064
180. S.B. King III, and B. Meier Interventional treatment of coronary heart disease and peripheral vascular disease Circulation 102 2000 IV81 IV86
181. U. Sigwart, J. Puel, V. Mirkovitch, F. Joffre, and L. Kappenberger Intravascular stents to prevent occlusion and re-stenosis after transluminal angioplasty N Engl J Med 316 1987 701 706
182. M.A. Costa, and D.I. Simon Molecular basis of restenosis and drug-eluting stents Circulation 111 2005 2257 2273
183. N.A. Scott Restenosis following implantation of bare metal coronary stents: pathophysiology and pathways involved in the vascular response to injury Adv Drug Deliv Rev 58 2006 358 376
184. C. Herdeg, M. Oberhoff, A. Baumbach, A. Blattner, D.I. Axel, S. Schroder, H. Heinle, and K.R. Karsch Local paclitaxel delivery for the prevention of restenosis: biological effects and efficacy in vivo J Am Coll Cardiol 35 2000 1969 1976
185. S.G. Raja Drug-eluting stents: is it the beginning of the end for coronary artery bypass surgery? Chin Med J 117 2004 1377 1387
186. O. Frobert, F. Schersten, S.K. James, J. Carlsson, and B. Lagerqvist Long-term safety and efficacy of drug-eluting and bare metal stents in saphenous vein grafts Am Heart J 164 2012 87 93
187. S. Garg, and P.W. Serruys Coronary stents: current status J Am Coll Cardiol 56 2010 S1 S42
188. S. Bangalore, B. Toklu, N. Amoroso, M. Fusaro, S. Kumar, E.L. Hannan, D.P. Faxon, and F. Feit Bare metal stents, durable polymer drug eluting stents, and biodegradable polymer drug eluting stents for coronary artery disease: mixed treatment comparison meta-analysis BMJ 347 2013 f6625/1-20
189. R.A. Byrne, A. Kastrati, S. Massberg, A. Wieczorek, K.L. Laugwitz, M. Hadamitzky, S. Schulz, J. Pache, M. Fusaro, J. Hausleiter, A. Schömig, and J. Mehilli Biodegradable polymer versus permanent polymer drug-eluting stents and everolimus- versus sirolimus-eluting stents in patients with coronary artery disease 3-year outcomes from a randomized clinical trial J Am Coll Cardiol 58 2011 1325 1331
190. A. Abizaid, and J.R. Costa New drug-eluting stents: an overview on biodegradable and polymer-free next-generation stent systems Circ Cardiovasc Interv 3 2010 384 393
191. S.J. Denardo, P.L. Carpinone, D.M. Vock, C.D. Batich, and C.J. Pepine Changes to polymer surface of drug-eluting stents during balloon expansion JAMA 307 2012 2148 2150
192. S.J. Denardo, P.L. Carpinone, D.M. Vock, J.E. Tcheng, H.R. Phillips III, B.J. Willenberg, C.D. Batich, and C.J. Pepine Detailed analysis of polymer response to delivery balloon expansion of drug-eluting stents versus bare metal stents EuroIntervention 9 2013 389 397
193. S.H. Nam, H.Y. Nam, J.R. Joo, I.S. Baek, and J.S. Park Curcumin-loaded PLGA nanoparticles coating onto metal stent by electrophoretic deposition techniques Bull Korean Chem Soc 28 2007 397 402
194. J.R. Joo, H.Y. Nam, S.H. Nam, I. Baek, and J.S. Park A novel deposition method of PLGA nanoparticles on coronary stents Bull Korean Chem Soc 30 2009 1085 1087
195. L. Indolfi, F. Causa, C. Giovino, F. Ungaro, F. Quaglia, and P.A. Netti Microsphere-integrated drug-eluting stents: PLGA microsphere integration in hydrogel coating for local and prolonged delivery of hydrophilic antirestenosis agents J Biomed Mater Res Part A 97 2011 201 211
196. R. Berg, J. Aragon, V. Royter, J.F. Shanley, G. Cogert, R. Vermani, S. Kar, N. Eigler, and F. Litvack Pimecrolimus and dual pimecrolimus-paclitaxel eluting stents decrease neointimal proliferation in a porcine model Catheter Cardiovasc Interv 70 2007 871 879
197. J.J. Kleinedler, J.D. Foley, J.S. Alexander, S.C. Roerig, V.Y. Hebert, and T.R. Dugas Synergistic effect of resveratrol and quercetin released from drug-eluting polymer coatings for endovascular devices J Biomed Mater Res Part B 99 2011 266 275
198. A. Tan, M.S. Alavijeh, and A.M. Seifalian Next generation stent coatings: convergence of biotechnology and nanotechnology Trends Biotechnol 30 2012 406 409
199. Y. Liu, W. Wang, G. Acharya, Y.B. Shim, E. Choe, and C. Lee Advanced stent coating for drug delivery and in vivo biocompatibility J Nanopart Res 15 2013 1 16
200. L. Lei, X. Liu, S. Guo, M. Tang, L. Cheng, and L. Tian 5-Fluorouracil-loaded multilayered films for drug controlled releasing stent application: drug release, microstructure, and ex vivo permeation behaviors J Controlled Release 146 2010 45 53
201. F. Lu, Y.Y. Shen, Y.Q. Shen, J.W. Hou, Z.M. Wang, and S.R. Guo Treatments of paclitaxel with poly(vinyl pyrrolidone) to improve drug release from poly(ϵ-caprolactone) matrix for film-based stent Int J Pharm 434 2012 161 168
202. N. Bege, S.O. Steinmüller, M. Kalinowski, R. Reul, S. Klaus, H. Petersen, C. Curdy, J. Janek, and T. Kissel Drug eluting stents based on poly(ethylene carbonate): optimization of the stent coating process Eur J Pharm Biopharm 80 2012 562 570
203. Y.J. Wang, T.Y. Lo, C.H. Wu, and D.M. Liu Electrophoretic coating of amphiphilic chitosan colloids on regulating cellular behaviour J R Soc Interface 10 2013 20130411/1-11
204. K. Larsen, C. Cheng, D. Tempel, S. Parker, S. Yazdani, W.K. den Dekker, J.H. Houtgraaf, R. de Jong, S. Swager-ten Hoor, E. Ligtenberg, S.R. Hanson, S. Rowland, F. Kolodgie, P.W. Serruys, R. Virmani, and H.J. Duckers Capture of circulatory endothelial progenitor cells and accelerated re-endothelialization of a bio-engineered stent in human ex vivo shunt and rabbit denudation model Eur Heart J 33 2012 120 128
205. A. Tan, Y. Farhatnia, D. Goh, G.N. de Mel, A. Lim, J. Teoh, S.H. Malkovskiy, A. Chawla, R. Rajadas, J. Cousins, B. Hamblin, M. Alavijeh, and M.A. Seifalian Surface modification of a polyhedral oligomeric silsesquioxane poly(carbonate-urea) urethane (POSS-PCU) nanocomposite polymer as a stent coating for enhanced capture of endothelial progenitor cells Biointerphases 8 2013 1 18
206. Ajazuddin, A. Alexander, J. Khan, T.K. Giri, D.K. Tripathi, S. Saraf, and S. Saraf Advancement in stimuli triggered in situ gelling delivery for local and systemic route Expert Opin Drug Deliv 9 2012 1573 1592
207. E. Ruel-Gariépy, and J.C. Leroux In situ-forming hydrogels - review of temperature-sensitive systems Eur J Pharm Biopharm 58 2004 409 426
208. E.R. Edelman, D.H. Adams, and M.J. Karnovsky Effect of controlled adventitial heparin delivery on smooth muscle cell proliferation following endothelial injury Proc Nat Acad Sci USA 87 1990 3773 3777
209. A.E. Villa, L.A. Guzman, W. Chen, G. Golomb, R.J. Levy, and E.J. Topol Local delivery of dexamethasone for prevention of neointimal proliferation in a rat model of balloon angioplasty J Clin Invest 93 1994 1243 1249
210. A. Dalmoro, A.A. Barba, M. Grassi, G. Grassi, and G. Lamberti In situ coronary stent paving by Pluronic F127-alginate gel blends: formulation and erosion tests J Biomed Mater Res Part B 2015 10.1002/jbm.b.33425
211. C.M. Terry, L. Li, H. Li, I. Zhuplatov, D.K. Blumenthal, S.E. Kim, S.C. Owen, E.G. Kholmovski, K.D. Fowers, R. Rathi, and A.K. Cheung In vivo evaluation of the delivery and efficacy of a sirolimus-laden polymer gel for inhibition of hyperplasia in a porcine model of arteriovenous hemodialysis graft stenosis J Controlled Release 160 2012 459 467
212. S.C. Owen, H. Li, W.G. Sanders, A.K. Cheung, and C.M. Terry Correlation of tissue drug concentrations with in vivo magnetic resonance images of polymer drug depot around arteriovenous graft J Controlled Release 146 2010 23 30
213. T. Masaki, R. Rathi, G. Zentner, J.K. Leypoldt, S.F. Mohammad, G.L. Burns, L. Li, S. Zhuplatov, T. Chirananthavat, S.J. Kim, S. Kern, J. Holman, S.W. Kim, and A.K. Cheung Inhibition of neointimal hyperplasia in vascular grafts by sustained perivascular delivery of paclitaxel Kidney Int 66 2004 2061 2069
214. M.H. Hsiao, M. Larsson, A. Larsson, H. Evenbratt, Y.Y. Chen, Y.Y. Chen, and D.M. Liu Design and characterization of a novel amphiphilic chitosan nanocapsule-based thermo-gelling biogel with sustained in vivo release of the hydrophilic anti-epilepsy drug ethosuximide J Controlled Release 161 2012 942 948
215. L.J. Lin, M. Larsson, and D.M. Liu A novel dual-structure, self-healable, polysaccharide based hybrid nanogel for biomedical uses Soft Matter 7 2011 5816 5825
216. M. Larsson, A. Bergstrand, L. Mesiah, C. Van Vooren, and A. Larsson Nanocomposites of polyacrylic acid nanogels and biodegradable polyhydroxybutyrate for bone regeneration and drug delivery J Nanomater 2014 2014 371307/1-9
217. E. Ruel-Gariépy, G. Leclair, P. Hildgen, A. Gupta, and J.C. Leroux Thermosensitive chitosan-based hydrogel containing liposomes for the delivery of hydrophilic molecules J Controlled Release 82 2002 373 383
218. Z. Gu, A.A. Aimetti, Q. Wang, T.T. Dang, Y. Zhang, O. Veiseh, H. Cheng, R.S. Langer, and D.G. Anderson Injectable nano-network for glucose-mediated insulin delivery ACS Nano 7 2013 4194 4201
219. Y.D. Lin, M.Y. Chang, B. Cheng, Y.W. Liu, L.C. Lin, J.H. Chen, and P.C.H. Hsieh Injection of peptide nanogels preserves postinfarct diastolic function and prolongs efficacy of cell therapy in pigs Tissue Eng Part A 21 2015 1662 1671
220. Y.D. Lin, M.L. Yeh, Y.J. Yang, D.C. Tsai, T.Y. Chu, Y.Y. Shih, M.Y. Chang, Y.W. Liu, A.C.L. Tang, T.Y. Chen, C.Y. Luo, K.C. Chang, J.H. Chen, H.L. Wu, T.K. Hung, and P.C.H. Hsieh Intramyocardial peptide nanofiber injection improves postinfarction ventricular remodeling and efficacy of bone marrow cell therapy in pigs Circulation 122 2010 S132 S141
221. J.M. Singelyn, P. Sundaramurthy, T.D. Johnson, P.J. Schup-Magoffin, D.P. Hu, D.M. Faulk, J. Wang, K.M. Mayle, K. Bartels, M. Salvatore, A.M. Kinsey, A.N. DeMaria, N. Dib, and K.L. Christman Catheter-deliverable hydrogel derived from decellularized ventricular extracellular matrix increases endogenous cardiomyocytes and preserves cardiac function post-myocardial infarction J Am Coll Cardiol 59 2012 751 763
222. S. Ren, X. Jiang, Z. Li, Y. Wen, D. Chen, X. Li, X. Zhang, R. Zhuo, and H. Chu Physical properties of poly(N-isopropylacrylamide) hydrogel promote its effects on cardiac protection after myocardial infarction J Int Med Res 40 2012 2167 2182
223. N.J.R. Blackburn, T. Sofrenovic, D. Kuraitis, A. Ahmadi, B. McNeill, C. Deng, K.J. Rayner, Z. Zhong, M. Ruel, and E.J. Suuronen Timing underpins the benefits associated with injectable collagen biomaterial therapy for the treatment of myocardial infarction Biomaterials 39 2015 182 192
224. X. Zhang, H. Wang, X. Ma, A. Adila, B. Wang, F. Liu, B. Chen, C. Wang, and Y. Ma Preservation of the cardiac function in infarcted rat hearts by the transplantation of adipose-derived stem cells with injectable fibrin scaffolds Exp Biol Med 235 2010 1505 1515
225. K.A. Garvin, J. VanderBurgh, D.C. Hocking, and D. Dalecki Controlling collagen fiber microstructure in three-dimensional hydrogels using ultrasound J Acoust Soc Am 134 2013 1491 1502
226. A.C. Brown, and T.H. Barker Fibrin-based biomaterials: modulation of macroscopic properties through rational design at the molecular level Acta Biomater 10 2014 1502 1514
227. J.O. Mangual, S. Li, H.J. Ploehn, A.D. Ebner, and J.A. Ritter Biodegradable nanocomposite magnetite stent for implant-assisted magnetic drug targeting J Magn Magn Mater 322 2010 3094 3100
228. R. Gordon, S.M. Levin, and I.C. Gebeshuber Triggered, nanostructured biodegradables (TNBs) for surgical implants Micro Nanosyst 3 2011 284 289
229. S. Venkatraman, F. Boey, and L.L. Lao Implanted cardiovascular polymers: natural, synthetic and bio-inspired Prog Polym Sci 33 2008 853 874
230. R. Rai, M. Tallawi, A. Grigore, and A.R. Boccaccini Synthesis, properties and biomedical applications of poly(glycerol sebacate) (PGS): a review Prog Polym Sci 37 2012 1051 1078
231. J. Daemen, and P.W. Serruys Drug-eluting stent update 2007: Part I. A survey of current and future generation drug-eluting stents: meaningful advances or more of the same? Circulation 116 2007 316 328
232. P.A. Lemos, P.W. Serruys, and J.E. Sousa Drug-eluting stents: cost versus clinical benefit Circulation 107 2003 3003 3007
233. A.P. Amin, J.A. Spertus, D.J. Cohen, A. Chhatriwalla, K.F. Kennedy, K. Vilain, A.C. Salisbury, L. Venkitachalam, S.M. Lai, L. Mauri, S.L. Normand, J.S. Rumsfeld, J.C. Messenger, and R.W. Yeh Use of drug-eluting stents as a function of predicted benefit: clinical and economic implications of current practice Arch Intern Med 172 2012 1145 1152
234. J. Margolis, J. McDonald, R. Heuser, P. Klinke, R. Waksman, R. Virmani, N. Desai, and D. Hilton Systemic nanoparticle paclitaxel (nab-paclitaxel) for in-stent restenosis I (SNAPIST-I): a first-in-human safety and dose-finding study Clin Cardiol 30 2007 165 170
235. S. Mignani, S.E. Kazzouli, M. Bousmina, and J.P. Majoral Dendrimer space concept for innovative nanomedicine: a futuristic vision for medicinal chemistry Prog Polym Sci 38 2013 993 1008
236. J.M. Oliveira, A.J. Salgado, N. Sousa, J.F. Mano, and R.L. Reis Dendrimers and derivatives as a potential therapeutic tool in regenerative medicine strategies - a review Prog Polym Sci 35 2010 1163 1194
237. Y. Malam, M. Loizidou, and A.M. Seifalian Liposomes and nanoparticles: nanosized vehicles for drug delivery in cancer Trends Pharmacol Sci 30 2009 592 599
238. M. Larsson, A. Viridén, M. Stading, and A. Larsson The influence of HPMC substitution pattern on solid-state properties Carbohydr Polym 82 2010 1074 1081
239. A. Viridén, S. Abrahmsén-Alami, B. Wittgren, and A. Larsson Release of theophylline and carbamazepine from matrix tablets - consequences of HPMC chemical heterogeneity Eur J Pharm Biopharm 78 2011 470 479
240. A. Viridén, B. Wittgren, and A. Larsson Investigation of critical polymer properties for polymer release and swelling of HPMC matrix tablets Eur J Pharm Sci 36 2009 297 309
241. A. Viridén, B. Wittgren, T. Andersson, and A. Larsson The effect of chemical heterogeneity of HPMC on polymer release from matrix tablets Eur J Pharm Sci 36 2009 392 400